Embedded Player Drugs to treat attention deficit and hyperactivity disorder prompt continued debate. An advisory committee to the Food and Drug Administration has recommended "black box" warnings for all, but a second panel, made up mostly of child psychiatrists and pediatricians, says the dangers do not merit such a warning.